🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

With high BMI, I tend to never reduce the dose, and apparently, it’s the right choice. Thanks Francis Couturaud INNOVTE for those amazing data. Greatful to have participated in this amazing study.

I would like to draw attention to this figure and this article , which highlights well the different dimensions to consider in patient management.

🧵👀 1. Let’s look at the notable pathbreaking 2024 articles Thread 🪡 NEJM

I wonder how many doctors who treat venous thromboembolism have ever heard of the Westermark's and Palla's signs in pulmonary embolism. This is the clinical image in NEJM this week.

New data about the course of patients with #CAT undergoing a @VTE recurrence. Data from a large Natiowide Cohort Study.RPTH Laurent Bertoletti

Patients treated by female physicians have better outcomes than those treated by men- our work led by Kiyan Heybati and Angela Jerath MD, MSc published today ➡️ bmchealthservres.biomedcentral.com/counter/pdf/10… Physician patient concordance associated with better outcomes particularly between female

Practicing medicine hinges on two essential skills: 1. Understanding the balance of risk vs. benefit in treatments. 2. Clearly communicating these risks and benefits to patients, empowering them to make informed decisions.

Science Behind the Study: Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI nej.md/3Eg76gw #Cardiology

Sufficient thrombin generation is the aim of all non replacement therapies in #hemophilia. #eahad25

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial - The Lancet thelancet.com/journals/lance… INNOVTE

Save the date for the next French Vascular medicine congress!

Encore un truc inacceptable qu'on a normalisé

Presented at #ACC25: In the API-CAT trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events. Full trial results:

Practice-changing paper in @nejm by Mahé Isabelle Marc Carrier API-CAT team proves that apixaban dose can be reduced after 6mo of anticoag rx with no loss of efficacy and less bleeding. Congrats to the team! nejm.org/doi/full/10.10…

Thread of natural sources of different medications. We can thank the Gila Monster for modern GLP-1 drugs like Ozempic

The anticoagulant potency of #DOAC differs according to the individual procoagulant potential. Highly procoagulant plasmas from patients withcirrhosis are less sensitive to the anticoagulant action of apixaban, edoxaban, and rivaroxaban compared to control jthjournal.org/article/S1538-…

The Anatomy Lesson of Dr. Nicolaes Tulp, by Rembrandt, 1632 #histmed #DutchGoldenAge #anatomy #doctor #medstudent #medschool #pastmedicalhistory

🔴Acute Pulmonary Embolism Management⤵️ #2025Review #openaccess 🔹link.springer.com/article/10.100… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter

World Hypertension Day: 10 Ways to Lower Your Blood Pressure 1️⃣ Healthy Diet: 11 mmHg 2️⃣ Isometric Exercises: 10/11 mmHg 3️⃣ Stress Reduction: 6/7 mmHg 4️⃣ Aerobic Exercises: 5/6 mmHg 5️⃣ 1Kg Weight loss: 5mmHg 6️⃣ Reduced sodium intake: 5/6 mmHg 7️⃣ Resistance Training: 4 mmHg 8️⃣

Pernod Dr Jean Pierre Laroche #vacciné 6.0 SFMV Club des Jeunes Médecins Vasculaires Marie Sevestre Guillaume Mahé MDPhD Le référentiel 2eme cycle de médecine et chirurgie vasculaire 4EME édition 2025 est disponible en librairie